Federal Court Blocks Mailing of Abortion Pill Mifepristone, Impacting Access Nationwide
A federal appeals court has issued a ruling that restricts the distribution of the abortion pill mifepristone by mail, requiring it to be dispensed only in person at clinics. This decision by the 5th U.S. Circuit Court of Appeals marks a significant development in U.S. abortion policy following the overturning of Roe v. Wade. The ruling is seen as a victory for abortion opponents who argue that mailing the pill undermines state bans on abortion. The case, which is expected to be appealed to the U.S. Supreme Court, affects all states, including those without abortion restrictions. The ruling challenges the FDA's regulations, which had allowed the pill to be prescribed online and mailed, a practice that has become a focal point for abortion opponents. 
